RxDoctor Payments Data

Mohammed Jaweed

Nurse Practitioner · Beckley, WVNPI 1164987574

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,681in general payments, 2019–2025

Across 152 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$524
  • Pfizer$188
  • Lilly USA, LLC$166
  • Biohaven Pharmaceutical Holding Company Ltd.$140
  • Otsuka America Pharmaceutical, Inc.$136
  • Vanda Pharmaceuticals Inc.$128
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$2,681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,681 in reported general payments places this provider in the 90th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Medicare billing

Part B allowed, 2024
$14,518
Medicare patients
123
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$18,178
JardianceEmpagliflozin15$17,079
JanuviaSitagliptin Phosphate13$15,879
Nurtec OdtRimegepant Sulfate11$10,810
BrilintaTicagrelor19$9,327
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl23$1,584
Albuterol Sulfate HfaAlbuterol Sulfate26$864
Ranolazine ErRanolazine22$695
Gabapentin69$609
Famotidine62$420
Pantoprazole Sodium50$404
Atorvastatin Calcium61$373
Montelukast Sodium61$330
Omeprazole43$328
Potassium Chloride22$300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$188$28,98832 claims
Boehringer IngelheimJardiance$23$17,07915 claims
MerckJanuvia$27$15,87913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 649 nurse practitioner providers in West Virginia.

Other nurse practitioner in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →